Coronavirus Testing Trials -- Professor Andrew Pollard Interview

The video discusses the number of vaccine doses required, particularly for older adults who may have a weaker immune response. It highlights the responsibilities involved in vaccine development and the importance of maintaining integrity in clinical trials. The challenges of scaling up vaccine production to meet global demand are also addressed, along with the global efforts to find solutions for widespread distribution.

How many doses of vaccine are currently planned to be given to people?

What is the concern regarding the immune response of older adults to vaccines?

What is the significance of conducting trials in older adults?

What challenges are associated with scaling up vaccine production?

What is the global requirement for vaccine doses mentioned in the text?